Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine

PDF  | 

Print  | 

E-mail

     

     

“Biocell Center has been working with perinatologists and Ob/Gyn doctors worldwide for several years,” said Kate Torchilin, CEO of Biocell Center Corporation. “We understand the effects that high-risk pregnancy can have on mothers and families and we are hoping to inform women undergoing amniocentesis that they have a unique opportunity to cryopreserve amniotic fluid stem cells as a biological insurance for the future.”

Biocell Center Corporation - the only company in the world offering the private preservation of amniotic fluid cells - attended the SMFM meeting in Chicago this week for the first time since it opened for business in the United States in late 2009.

Other press releases from Biocell Center

• Biocell Center Corporation Partners with New England’s Largest Community-Based Hospital Network to Offer a Unique Service in Amniotic Fluid Stem Cell Preservation - March 8th, 2010
• Stem Cells from Amniocentesis: Biocell Center Partners With Innovative Medical Solutions to Distribute Its Service in the New York Area - February 1st, 2010